316 related articles for article (PubMed ID: 23811337)
1. Honokiol: a non-adipogenic PPARγ agonist from nature.
Atanasov AG; Wang JN; Gu SP; Bu J; Kramer MP; Baumgartner L; Fakhrudin N; Ladurner A; Malainer C; Vuorinen A; Noha SM; Schwaiger S; Rollinger JM; Schuster D; Stuppner H; Dirsch VM; Heiss EH
Biochim Biophys Acta; 2013 Oct; 1830(10):4813-9. PubMed ID: 23811337
[TBL] [Abstract][Full Text] [Related]
2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
3. Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes.
Choi SS; Cha BY; Iida K; Sato M; Lee YS; Teruya T; Yonezawa T; Nagai K; Woo JT
J Nat Med; 2011 Jul; 65(3-4):424-30. PubMed ID: 21327521
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells.
Chen HC; Hsu HT; Weng JW; Chang YF; Hsia CY; Lee HC; Chi CW
J Chin Med Assoc; 2016 Aug; 79(8):415-21. PubMed ID: 27094504
[TBL] [Abstract][Full Text] [Related]
5. Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma.
Atanasov AG; Blunder M; Fakhrudin N; Liu X; Noha SM; Malainer C; Kramer MP; Cocic A; Kunert O; Schinkovitz A; Heiss EH; Schuster D; Dirsch VM; Bauer R
PLoS One; 2013; 8(4):e61755. PubMed ID: 23630612
[TBL] [Abstract][Full Text] [Related]
6. A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.
Choi SS; Kim ES; Koh M; Lee SJ; Lim D; Yang YR; Jang HJ; Seo KA; Min SH; Lee IH; Park SB; Suh PG; Choi JH
J Biol Chem; 2014 Sep; 289(38):26618-26629. PubMed ID: 25100724
[TBL] [Abstract][Full Text] [Related]
7. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review.
Wang L; Waltenberger B; Pferschy-Wenzig EM; Blunder M; Liu X; Malainer C; Blazevic T; Schwaiger S; Rollinger JM; Heiss EH; Schuster D; Kopp B; Bauer R; Stuppner H; Dirsch VM; Atanasov AG
Biochem Pharmacol; 2014 Nov; 92(1):73-89. PubMed ID: 25083916
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3-L1 cells.
Nakashima KI; Okamura M; Matsumoto I; Kameda N; Tsuboi T; Yamaguchi E; Itoh A; Inoue M
J Nat Med; 2023 Mar; 77(2):315-326. PubMed ID: 36607539
[TBL] [Abstract][Full Text] [Related]
10. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M
J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380
[TBL] [Abstract][Full Text] [Related]
11. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
[TBL] [Abstract][Full Text] [Related]
12. Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Chamorro-García R; Kirchner S; Li X; Janesick A; Casey SC; Chow C; Blumberg B
Environ Health Perspect; 2012 Jul; 120(7):984-9. PubMed ID: 22763116
[TBL] [Abstract][Full Text] [Related]
13. A Novel Partial PPARγ Agonist Has Weaker Lipogenic Effect in Adipocytes and Stimulates GLUT4 Translocation in Skeletal Muscle Cells via AMPK-Dependent Signaling.
Guru B; Tamrakar AK; Mandal SP; Kumar PBR; Sharma A; Manjula SN
Pharmacology; 2022; 107(1-2):90-101. PubMed ID: 34736259
[TBL] [Abstract][Full Text] [Related]
14. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
15. Zyflamend, a unique herbal blend, induces cell death and inhibits adipogenesis through the coordinated regulation of PKA and JNK.
Puckett D; Alquraishi M; Alani DS; Chahed S; Frankel VD; Donohoe D; Voy B; Whelan J; Bettaieb A
Adipocyte; 2020 Dec; 9(1):454-471. PubMed ID: 32779962
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.
Liu C; Feng T; Zhu N; Liu P; Han X; Chen M; Wang X; Li N; Li Y; Xu Y; Si S
Sci Rep; 2015 Apr; 5():9530. PubMed ID: 25827822
[TBL] [Abstract][Full Text] [Related]
17. Linked magnolol dimer as a selective PPARγ agonist - Structure-based rational design, synthesis, and bioactivity evaluation.
Dreier D; Latkolik S; Rycek L; Schnürch M; Dymáková A; Atanasov AG; Ladurner A; Heiss EH; Stuppner H; Schuster D; Mihovilovic MD; Dirsch VM
Sci Rep; 2017 Oct; 7(1):13002. PubMed ID: 29057944
[TBL] [Abstract][Full Text] [Related]
18. A novel specific peroxisome proliferator-activated receptor γ (PPARγ) modulator YR4-42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet-induced obese mice.
Huan Y; Pan X; Peng J; Jia C; Sun S; Bai G; Wang X; Zhou T; Li R; Liu S; Li C; Liu Q; Liu Z; Shen Z
Diabetes Obes Metab; 2019 Nov; 21(11):2553-2563. PubMed ID: 31364797
[TBL] [Abstract][Full Text] [Related]
19. Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor gamma.
Fakhrudin N; Ladurner A; Atanasov AG; Heiss EH; Baumgartner L; Markt P; Schuster D; Ellmerer EP; Wolber G; Rollinger JM; Stuppner H; Dirsch VM
Mol Pharmacol; 2010 Apr; 77(4):559-66. PubMed ID: 20064974
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
